European stocks gain as bond yields ease

Fidelity European Trust

European stocks moved higher on Tuesday as bond yields eased and risk appetite improved, giving markets a firmer start after last week’s sharp sell-off.

The STOXX Europe 600 rose 0.8% to 638.41 points, putting the index on course for a third consecutive session of gains and close to a one-week high. Futures had already pointed to a stronger opening, with Euro Stoxx 50 and STOXX 600 futures both around 0.4% higher before trading began.

The recovery is being supported by a pause in the recent rise in government bond yields. Eurozone yields reached multi-decade highs last week amid concerns over inflation and government finances, placing pressure on equity valuations. Their retreat is now giving European shares some breathing room.

Technology and artificial intelligence stocks were among the areas supporting the stronger opening, while healthcare also performed particularly well.

Healthcare stocks gained 1.6%, led by Genmab, which climbed 7.6% after the Danish biotechnology company and AbbVie reported positive late-stage results for their blood cancer drug combination. The treatment reduced the risk of disease progression or death, making Genmab the strongest performer on the STOXX 600.

The move in Genmab demonstrates the potential for positive company-specific news to drive individual stocks even while the wider market remains focused on interest rates, government borrowing and political uncertainty.

Technology-related shares also benefited from the improved risk tone. Italian semiconductor testing company Technoprobe gained 2.3% after JPMorgan initiated coverage with an overweight rating.

The wider European market is now looking towards a series of economic indicators that could provide further direction. German factory orders, French industrial production and eurozone retail sales are due, alongside construction activity data from across Europe.

The data will give investors a clearer picture of the underlying strength of the European economy at a time when markets are balancing concerns over inflation and government finances against resilient demand.

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

European stocks hit record high on strong corporate earnings

European stocks hit a new record as companies deliver stronger earnings, with the STOXX 600 outperforming US markets during...

Fidelity European Trust research highlights portfolio value and investment strategy

New research from Kepler Trust Intelligence examines Fidelity European Trust's investment performance, portfolio holdings and outlook, highlighting its long-term...

European stocks recover as banking and technology shares lead market gains

European shares advance as technology and banking stocks lead a market recovery, with stronger corporate earnings, lower oil prices...

Fidelity European Trust Manager Marcel Stötzel sees opportunities in European equities, AI and defence

Fidelity European Trust portfolio manager Marcel Stötzel discusses the outlook for European equities, AI opportunities, ASML, Schneider Electric, Roche...

Fidelity European Trust Plc: ASML and MTU gains support performance in weaker September

Fidelity European Trust PLC modestly outperformed its benchmark in September 2026, supported by stock selection in industrials, consumer discretionary...

European stocks rise as investors await Central Bank decisions and earnings

European stocks edged higher as investors assessed oil prices, company earnings and upcoming ECB and Federal Reserve interest rate...

Search